trending Market Intelligence /marketintelligence/en/news-insights/trending/ejwMjSDt7Qz4a-H8l0OVtw2 content esgSubNav
In This List

Flexion Therapeutics starts common stock offering

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Flexion Therapeutics starts common stock offering

Flexion Therapeutics Inc. started an underwritten public offering for 4 million common shares.

The specialty pharmaceutical company plans to grant underwriters an option to buy up to an additional 15% of the shares offered.

Net proceeds will be used to fund manufacturing and commercialization of company's drug Zilretta, product pipeline development, and for working capital and general corporate purposes.

Wells Fargo Securities, BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers.